Chemical activators of C2orf79 include a range of compounds that initiate intracellular signaling cascades resulting in the protein's activation. Forskolin is one such activator that directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels within the cell. The elevated cAMP activates protein kinase A (PKA), which can then phosphorylate C2orf79, thereby activating it. Similarly, dibutyryl-cAMP and 8-Bromo-cAMP, both cAMP analogs, serve the same purpose by activating PKA, which, in turn, can phosphorylate and activate C2orf79. Isoproterenol also raises cAMP levels by acting as a β-adrenergic agonist, which indirectly leads to C2orf79 activation via PKA.
Another activator, Ionomycin, facilitates the influx of calcium ions and elevates intracellular calcium levels, which can activate calcium-dependent kinases capable of phosphorylating C2orf79. Thapsigargin also raises intracellular calcium by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially leading to the activation of C2orf79 by similar calcium-dependent mechanisms. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which may then phosphorylate C2orf79, leading to its activation. The role of kinase activation is further supported by the use of compounds like Anisomycin, which activates stress-activated protein kinases that can also phosphorylate and activate C2orf79. Calyculin A and Okadaic Acid, both inhibitors of protein phosphatases, prevent the dephosphorylation of C2orf79, thereby maintaining it in an active state. Additionally, Epidermal Growth Factor (EGF) triggers the MAPK/ERK pathway, which is known to lead to the phosphorylation of various proteins and may include C2orf79 activation within its signaling relay. Insulin activates the PI3K/Akt pathway, another signaling cascade that often results in protein phosphorylation, and this can include the phosphorylation and subsequent activation of C2orf79. Each chemical, through its respective pathway, ensures that C2orf79 is phosphorylated and activated, which is essential for its function within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
| Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
| Increases intracellular calcium, which can activate calcium-dependent kinases that phosphorylate C2orf79. | ||||||
| PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
| Activates protein kinase C (PKC), which can phosphorylate and thus activate C2orf79. | ||||||
| Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
| Inhibits protein phosphatases, maintaining C2orf79 in an active, phosphorylated state. | ||||||
| Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
| Inhibits protein phosphatases leading to the sustained activation of C2orf79 through phosphorylation. | ||||||
| Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
| Activates PI3K/Akt pathway, potentially resulting in the phosphorylation and activation of C2orf79. | ||||||
| Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
| Activates stress-activated protein kinases that can phosphorylate and activate C2orf79. | ||||||
| Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
| Elevates intracellular calcium by inhibiting SERCA, possibly leading to the activation of C2orf79. | ||||||
| Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
| cAMP analog that activates PKA, which in turn may phosphorylate and activate C2orf79. | ||||||
| 8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
| cAMP analog that activates PKA possibly leading to the phosphorylation and activation of C2orf79. | ||||||
| Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
| β-adrenergic agonist that increases cAMP levels, leading to the activation of C2orf79 through PKA. | ||||||